FDA Approves AstraZeneca’s Etcamah for Advanced Breast Cancer
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Etcamah (camizestrant) for certain adults with advanced breast cancer, expanding treatment…
Read More...
Read More...
